Background: Non-structural protein 5 (NS5) of dengue virus serotype 2 is predominantly nuclear localized.
contains a single long open reading frame (ORF). The ORF encodes a large polyprotein that is coand post-translationally processed by host and the viral encoded NS2B/3 proteinase to yield the three structural proteins capsid, premembrane/membrane and envelope and the seven non-structural (NS) proteins NS1, NS2A, NS2B, NS3, NS4A, NS4B and NS5 (3) . NS5 is the largest (~105 kDa) and most well conserved of the flavivirus proteins. NS5 contains two domains. The N-terminal methyltransferase (MTase) domain contains N-7, 2-O-methyltransferase (4-5) and guanylyltransferase (6) enzymatic activities, all required for capping of the RNA genome. The Cterminal domain contains RNA-dependent RNApolymerase (POL) activity that is essential for replication of the RNA genome (7) (8) . The enzymatic activities of NS5 are major targets for the development of anti-viral compounds (9) (10) .
In addition to its role in capping and replication of the RNA genome, the NS5 of a number of flaviviruses has been shown to perturb the host innate immune response. The NS5 proteins of Japanese encephalitis virus, Langat virus (LGTV), tick-borne encephalitis virus (TBEV) and West Nile virus (WNV) have been shown to inhibit type I IFN signalling by interfering with STAT1 activation (11) (12) (13) (14) whilst for DENV-2, NS5 binds to STAT2 and targets it for degradation (15) (16) . The interaction is species specific as DENV-2 NS5 binds to human but not murine STAT2 (17) . In addition, 2-Omethylation of the viral RNA cap structure by the WNV NS5 protein modulates the anti-viral effects of IFN-induced proteins with tetratricopeptide repeats (18) . Specific host cells can also prevent the actions of NS5, as evidenced by the finding that the NS5 of the tick-borne viruses LGTV and TBEV are actively targeted for degradation by tripartite motif protein 79α (19) .
Flavivirus genome replication, which depends on the enzymatic activities of NS5, occurs in the cytoplasm of infected host cells in association with perinuclear endoplasmic reticulum membranes (20) . However, NS5 of a number of flaviviruses including DENV-2, Japanese encephalitis virus, yellow fever virus, and TBEV have been detected in the nucleus of infected cells (reviewed in (21) ). Nuclear transport of proteins > 45 kDa is an active process that depends on proteins of the karyopherin-β family (also termed importins and exportins). Karyopherin family members may bind directly to cargo proteins via nuclear localization sequences (NLS) or nuclear export sequences (NES) before interacting with proteins in the nuclear pore complex to mediate nuclear/cytoplasmic transport (22) (23) . In the well characterized "classical nuclear import pathway", a NLS in the cargo protein is first recognized by the adaptor protein importin- (karyopherin- (KPNA)) which in turn is bound by importin-β (karyopherin-β1 (KPNB1)) to form a complex that is transported through the nuclear pore complex. Once in the nucleus, the cargo protein is released when Ran-GTP binds to importin-β. Importin- is known to bind to two different NLS sequences, a monopartite NLS consisting of a single stretch of basic amino acids or a bipartite NLS consisting of two stretches of basic amino acids separated by a 10 -12 amino acid linker region (24) (25) (26) .
Following the initial finding that DENV-2 NS5 accumulates in the nucleus during infection (27) , subsequent studies defined a functional bipartite NLS (termed the a/bNLS) in a stretch of 37 amino acids (369 -405) in the NS5 POL domain (28) . A murine importin-/importin-β heterodimer was found to bind with high affinity to the a/bNLS fused to β-galactosidase or the full length NS5 (28) (29) (30) . Mutagenesis studies defined a "minimal" a/bNLS (amino acid residues 369 -389) containing two basic amino acid clusters important for nuclear localization both in vitro (29) and in vivo in the context of the viral lifecycle (30) . Interestingly, mutations in the a/bNLS that delayed NS5 nuclear localization resulted in decreased virus replication but increased production of IL-8 (30) . DENV-2 NS5 also contains a functional NES recognized by exportin 1 (CRM1) (31) in a stretch of amino acids (320 -368, termed the bNLS) that was found to bind directly to importin-β and DENV-2 NS3 (32) . These studies suggest that DENV-2 NS5 shuttles between the cytoplasm and nucleus of infected cells and that this process is important for virus replication and the regulation of IL-8 amounts.
However, to date, all studies on NS5 nuclear localization have been done on DENV-2 NS5. In this study we examined the nuclear localization of NS5 for all four DENV serotypes. We found serotypic differences in the nuclear localization of NS5, either when transiently expressed or produced during the virus lifecycle. More detailed comparative studies on the DENV-2 and -4 NS5 proteins that were predominantly localized to the nucleus and cytoplasm respectively, revealed that the differences in localization were due to the lack of a NLS in DENV-4 NS5. Surprisingly, siRNA knockdown of the human importin-α isoform KPNA2, homologous to the murine importin- isoform previously shown to bind to DENV-2 NS5, in cells either infected with DENV-2 or expressing NS5 alone did not substantially affect NS5 nuclear localization whereas siRNA knockdown of KPNB1 dramatically decreased NS5 nuclear localization. The results suggest that NS5 nuclear localization is not strictly required for virus replication but is more likely to have an auxiliary function in the lifecycle of specific DENV serotypes.
EXPERIMENTAL PROCEDURES
Cell lines and viruses Human lung carcinoma (A549), HEK293 and Huh-7 liver cells were cultured in DMEM (Invitrogen) supplemented with 0.1 nM non-essential amino acids and 10% FBS (Invitrogen). The cell line HEK-DV2-NS5F (Hannemann et al., manuscript in preparation) derived from Flp-In TM T-REx TM -293 cells (Invitrogen) was grown in the same medium supplemented with 15 g/ml blasticidin and 150 g/ml hygromycin. African green monkey kidney (Vero) cells, baby hamster kidney cells (BHK-21) and Aedes albopictus C6/36 cells were cultured as previously described (33) (34) . Mammalian and insect cells were maintained at 37 ºC and 28 ºC respectively and 5% CO 2 in a humidified atmosphere. The following viruses were used in this study: DENV-1 strain Hawaii (GenBank: EU848545), DENV-2 strain New Guinea C (NGC; GenBank: AF038403); DENV-3 strain H87 (GenBank: M93130) and DENV-4 strain H241 (GenBank: AY947539) (the DENV-1, 3 and 4 viruses were a kind gift from J. Mongkolsapaya, Imperial College London, UK). Viral stocks were prepared and titered, and cells infected with DENV as described previously for DENV-2 (33, 35) .
Plasmid construction pcDV-NS5F constructs: The DENV-2 NGC NS5 gene was simultaneously amplified by PCR from the DENV-2 strain NGC genomic length cDNA clone pDVWS601 (33) (34) and C-terminally FLAG tagged using the primers P1 and P2 (the sequence of the oligonucleotide primers used in this study are shown in supplemental Table 1 ). The DENV-1 strain Hawaii and DENV-4 strain H241 NS5 genes were simultaneously amplified by PCR from plasmid clones containing these sequences and Cterminally FLAG tagged using the primer combinations P3/P4 and P5/P6 respectively. The PCR fragments were cloned into pcDNA-3.1 (Invitrogen) to produce pcDV2-NS5F, pcDV1-NS5F and pcDV4-NS5F respectively. The DENV-3 strain Singapore (GenBank: AY662691) NS5 sequence was amplified by PCR from pcGFP-DV3-NS5F (see below) using the primers P7 and P8 and cloned into pcDNA3.1 to produce pcDV3-NS5F.
pcUb-DV-NS5F constructs: The mouse ubiquitin gene (GenBank: AF118402) was amplified by PCR from an existing plasmid (a kind gift from R. Bartenschlager, University of Heidelberg, Germany) using the primer combinations P9/P11 (DENV-2), P10/P12 (DENV-3) or P9/P13 (DENV-4). The PCR products were used as co-templates together with pcDV2-NS5F, pcDV3-NS5F or pcDV4-NS5F and the primer combinations P9/P14, P10/P15 and P9/P6 respectively in PCR reactions to produce gene fusions between ubiquitin and the DENV-2, -3 and -4 NS5 genes. The PCR products were cloned into pcDV2-NS5F, pcDV3-NS5F and pcDV4-NS5F to produce pcUb-DV2-NS5F, pcUb-DV3-NS5F and pcUb-DV4-NS5F respectively.
pcGFP-DV-NS5F constructs: A gene construct encoding a DENV-2 GFP-NS5-FLAG fusion protein was constructed by overlap PCR (OL-PCR) using the plasmid pEGFP (Clontech) and pcDV2-NS5F as templates and the primer combinations P16/P17 and P18/P19 respectively. The OL-PCR product obtained using primers P16 and P19 was cloned into pcDV2-NS5F to produce pcGFP-DV2-NS5F. A plasmid encoding GFP fused to NS5 from the DENV-3 strain Singapore was constructed in a four step OL-PCR strategy using as templates, pcGFP-DV2-NS5F and two plasmids encoding the DENV-3 MTase and POL domains. Initially an XbaI site in the MTase gene sequence was removed by OL-PCR mutagenesis without changing the amino acid sequence using primers P20, P21, P22 and P23. The GFP gene was PCR amplified from pcGFP-DV2-NS5F using primers P16 and P24 and joined to the DENV-3
MTase gene fragment by OL-PCR. The DENV-3 POL gene was amplified from the appropriate plasmid and C-terminally FLAG tagged using primers P25 and P26. The GFP-MTase and POL encoding fragments were joined in a stepwise cloning strategy and cloned into pcDNA3.1 to produce pcGFP-DV3-NS5F. Plasmids encoding GFP-NS5-FLAG fusion proteins for DENV-1 and -4 were constructed by amplifying the GFP gene from pcGFP-DV2-NS5F using primers P27 and P28, and cloning the fragments into pcDV1-NS5F and pcDV4-NS5F.
pcGFP-NS5-POL constructs: A 900 bp fragment was amplified by PCR from pcGFP-DV2-NS5F using primers P29 and P30 and used as a co-template together with pcGFP-DV2-NS5F in a second PCR amplification, using primers P29 and P31. The resulting 1.9 kb fragment was digested with XbaI/EcoRV and exchanged with the corresponding fragment of pcGFP-DV2-NS5F to produce pcGFP-DV2-POLF (encoding DENV-2 NS5 amino acids 274-900). A 1 kb fragment was amplified from pcGFP-DV4-NS5F using oligonucleotides P32 and P33. The fragment was digested with NotI/EcoRV and exchanged with the corresponding fragment from pcGFP-DV4-NS5F to produce pcGFP-DV4-POLF (encoding DENV-4 NS5 amino acids 274-900).
pcGFP-NS5-MTase constructs: Sequences encoding GFP N-terminally fused to the DENV-2 and -4 NS5 MTase domains (NS5 amino acids 1-273) were amplified by PCR from pcGFP-DV2-NS5F and pcGFP-DV4-NS5F using primers P34 and P35 (DENV-2) or P36 (DENV-4), respectively. The DENV-2 PCR product was digested with EcoRI/HindIII and exchanged with the EcoRI/HindIII fragment of pcGFP-DV2-NS5F resulting in pcGFP-DV2-MT. The DENV-4 PCR product was cleaved with XcmI/HindIII and exchanged with the XcmI/HindIII fragment of pcGFP-DV4-NS5F resulting in pcGFP-DV4-MT.
pc2xGFP-DV-NS5-a/bNLS constructs: The sequence encoding GFP was amplified by PCR from pcGFP-DV4-NS5F using the primers P37 and either P38 or P39 so that the amplified PCR products contained the DENV-2 or -4 NS5 a/bNLS sequences. These products were subsequently used as co-templates in a second PCR amplification step together with either pcDV2-NS5F or pcDV4-NS5F and primers P37/P40 or P37/P41 respectively. The PCR products were digested with NotI/HindIII and exchanged with the NotI/HindIII digested pcGFP-DV4-NS5F (which removed the DENV-4 NS5 sequence) resulting in the plasmids pc2xGFP-DV2-NLS and pc2xGFP-DV4-NLS.
pcGFP-DV2-NS5-DV4 (370-390) and pcGFP-DV2-NS5-DV4 , encoding GFP-DENV-2 NS5 fusion proteins containing DENV-4 NS5 amino acid residues 370 -390 and 370 -401 were constructed using a triple OL-PCR cloning strategy and the primer sets P27, P42, P43, P44, P45, P46 and P27, P42, P43, P47, P48, P46 respectively. pcGFP-DV4-NS5-DV2 (370-390) and pcGFP-DV4-NS5-DV2 (370-401) , encoding GFP-DENV-4 NS5 fusion proteins containing DENV-2 NS5 amino acid residues 370 -390 and 370 -401 were constructed using primer sets P27, P49, P50, P51, P52, P53 and P27, P49, P50, P54, P55, P53 respectively. The final OL-PCR products were introduced into the respective plasmids using the restriction sites NheI and EcoRV. Sequences encoding DENV-4 NS5 amino acid residues 370 -390 and 370 -401 were isolated from pcGFP-DV2-NS5-DV4 (370-390) and pcGFP-DV2-NS5-DV4 by AatII/MluI digest and cloned into the corresponding sites of the DENV-2 infectious cDNA clone pDVWS601, to produce pDV2/4-NS5 (370-390) and pDV2/4-NS5 (370-401) respectively.
Plasmids containing the coding sequences of KPNA1 (GenBank Acc: NR_026698), KPNA2 (NM_002266), KPNA3 (NM_002267), KPNA4 (NM_002268), KPNA6 (NM_012316) and KPNB1 (NM_002265) were constructed by amplification of the respective ORFs from available plasmids ((36-37), a kind gift from R. Depping, University of Lübeck, Germany) by PCR using primers P56/P57, P58/P59, P60/P61, P62/P63, P64/P65 and P66/P67 respectively, that added a 5 NheI (or ApaI for KPNB1) and a 3 NotI site to the PCR fragments. The PCR fragments were digested with NheI/NotI (or ApaI/NotI for KPNB1) and ligated with NheI/XhoI or ApaI/XhoI digested pcDNA3.1 and a NotI/XhoI linker encoding a V5-epitope tag and a stop codon at the 3 end. As the expression levels of the V5-tagged KPNA1 to KPNA4 proteins were low, the corresponding ORFs of KPNA1, KPNA2, KPNA3 and KPNA4 were transferred into the vector pEFlink2 ((38), a kind gift from S. Goodbourn, University of London, UK) to enhance gene expression. All plasmids produced in the study were verified by sequencing before use.
Plasmid were infected with DENV-2 or -4 at a multiplicity of infection (MOI) of 3 or mock infected. At 28 h post-infection, the cells were detached, washed twice with ice cold PBS and resuspended in hypotonic swelling buffer (10 mM Tris-HCl (pH 8.0), 10 mM NaCl, 1.5 mM MgCl 2 and proteinase inhibitors (cOmplete, mini, EDTA-free; Roche). After 10 min incubation on ice, the cells were passed 20 times through both 20 and 26 gauge needles to lyse the cells and detach the perinuclear membranes from the nucleus as previously described (39) . The lysates were centrifuged at 800 g for 10 min at 4 C. This process was repeated and the pellets combined and taken as the nuclear fraction. The supernatant was then centrifuged at 16,000 g for 20 min at 4 C to produce a heavy membrane pellet (16K) and a soluble cytoplasmic fraction. The nuclear and 16K pellets were resuspended in swelling buffer. All fractions were adjusted to 1X Laemmli sample buffer before SDS-PAGE analysis. SDS-PAGE and Western blotting was done as previously described (30) using antibodies against the DENV NS5 and E proteins (monoclonal antibody 4G2) and histone H3 (Cell Signalling).
Immunofluorescence assay (IFA) and confocal imaging Cells grown on glass cover slips in 24 well trays were either transfected with expression plasmids, infected with DENV or mock transfected / infected. At an appropriate time posttransfection / infection the cells were fixed with 4% formaldehyde in PBS for 5 min followed by permeabilization in 1% (v/v) Triton X-100 and then analyzed by IFA as previously described (30) using primary antibodies against NS5 (30), the DENV E protein, the FLAG epitope (Sigma), GFP (Roche), KPNA2 (Sigma), KPNB1 (Abcam) or the V5 epitope (Invitrogen / Sigma) and secondary antibodies coupled to Alexa-Fluor 568 or AlexaFluor 488 (Molecular Probes, Invitrogen). The affinity of the polyclonal rabbit antiserum raised against DENV-2 NS5 (30) to the DENV-1, -3 and -4 NS5 proteins was increased by cross absorption following the method of Miller et al., (40) . Cells were mounted in Vectashield containing DAPI (Vecta Laboratories). Confocal laser scanning microscopy (CLSM) was done using a Leica confocal microscope (TCS-SP2). Fluorescence recovery after photobleaching (FRAP) analysis was done on living cells expressing GFP fusion proteins using a Leica DMI6000 microscope equipped with a spinning disc system (PerkinElmer) and a Hamamatsu EMCCD camera. Fluorescence was quantified and data analyzed using Volocity 6.0 software (Perkin-Elmer).
Leptomycin B assays Vero and A549 cells were transfected with either pcGFP-DV2-NS5F or pcGFP-DV4-NS5F. At 16 h post-transfection, leptomycin B (LMB) (Sigma) was added to the culture media to a final concentration of 15 g/ml or not added and the cellular localization of GFP monitored at 5, 20, 60, 120 and 360 min posttreatment. At 360 min post-treatment, cells were fixed and analyzed by CLSM. The action of LMB was confirmed with a CRM1 dependant luciferase reporter assay. A549 cells were transfected with pRL-TK (Promega), pLUCSALRRE and either pRev ((41), kind gifts of A. Whitehouse, University of Leeds, UK) or no plasmid and treated with 15 g/ml LMB or left untreated. Dual luciferase assays were performed at 16 h posttreatment using a Dual-Luciferase Reporter Assay System (Promega) and luminescence was read on a Modulus single tube multimode reader (Turner Biosystems).
At least two independent experiments were performed for each assay with all readings performed in triplicate.
Co-immunoprecipitation (co-IP) assays HEK293 cells were co-transfected with plasmids encoding the proteins of interest. 24 h posttransfection, the cells were harvested, washed twice in cold PBS and then lysed by incubation in either lysis buffer 1 (TBS containing 1% (w/v) Brij97 (Sigma) and proteinase inhibitors (Complete, Roche)) or lysis buffer 2 (50 mM TrisHCl (pH 7.5), 150 mM NaCl and 1% Triton-X100 and proteinase inhibitors) for 30 min on ice followed by brief sonication. The lysates were centrifuged at 13,000 g for 10 min at 4 C and supernatants were incubated with either anti-V5 magnetic beads (MBL International), anti-FLAG ® M2 magnetic beads (Sigma) or GFP-Trap (Chromotek) for 16 h at 4 C with rotation. The anti-V5 or anti-FLAG ® M2 magnetic beads were then collected by magnetic separation and washed 3 times with either lysis buffer 1 or 2 respectively. Proteins were eluted from the beads by boiling in SDS-PAGE sample buffer for 5 min. The eluted proteins and input proteins in the total cell lysates were analyzed by SDS-PAGE and Western blotting as described above, using anti-FLAG and V5 antibodies. Eukaryotic expression plasmids encoding a FLAG tagged Ras-related C3 botulinum toxin substrate 1 protein ((Rac1-F) (42), a kind gift of N. Klugbauer, University of Freiburg, Germany) and human STAT2 (a kind gift of S. Goodbourn) were used for co-IP studies.
siRNA knockdown experiments HEK293 cells were transfected with either AllStars Negative Control siRNA-488 (Qiagen) or a pool of 4 siRNAs against KPNA2 or KPNB1 (Dharmacon) using DharmaFECT1 (Dharmacon), or cells were left untreated as controls. At 72 h post-siRNA transfection, the cells were infected with DENV-2, mock infected or transfected with pcDV2-NS5F. Alternatively, HEK-DV2-NS5F cells were transfected with the respective siRNA pools as described above and at 24 h post-siRNA transfection incubated in media containing 1g/ml doxycycline for a further 72 h. 96 h post siRNA transfection, the cells were either lysed in SDS-PAGE sample buffer and subjected to SDS-PAGE and Western blot analysis using antibodies against NS5, KPNA2 (Sigma) or KPNB1 (Abcam), or fixed and analyzed by IFA and CLSM as described above.
IL-8 luciferase reporter gene assaysHEK293 cells were co-transfected with either a plasmid encoding NS5 or the positive control pMal together with a plasmid containing a firefly luciferase reporter gene under control of the IL-8 promoter ((43), a kind gift of K. Fitzgerald, University of Massachusetts, USA) and pRL-TK (Promega). Dual luciferase assays were performed 16 h post-transfection as described above.
Quantitative RT-PCR (qRT-PCR) RNA was extracted using a SV Total RNA isolation kit (Promega), and reverse transcribed using ImPromII Reverse Transcriptase (Promega). qRT-PCR was performed using an ABsolute™ QPCR SYBR® Green mix (ABgene) and a Stratagene MX3500 cycler. The primer pairs P68/P69 and P70/P71 and were used for amplification of the IL-8 and neomycin resistance gene (NeoR) transcripts, respectively.
RESULTS
Differential nuclear localization of transiently expressed DENV-1 to 4 NS5Previous studies have shown that DENV-2 NS5 is nuclear localized in a range of cell types, both during infection and when expressed as a GFP-NS5 fusion protein (27, (30) (31) 40, (44) (45) (46) . In order to determine if nuclear localization is a general property of DENV NS5, the localization of different recombinant forms of NS5, transiently expressed in cells, was examined for all four DENV serotypes. Plasmids encoding NS5, either N-terminally tagged with GFP and C-terminally tagged with the FLAG epitope (pcGFP-DV-NS5F plasmids) or Cterminally tagged with the FLAG epitope only (pcDV-NS5F plasmids) were constructed using the DENV-1 to 4 NS5 genes. The pcDV-NS5F plasmids were used to transfect human A549 and HEK293 cells and the localization of NS5 examined by IFA and CLSM (Fig. 1A) . As previously reported, DENV-2 NS5 was nuclear localized in both cell lines, as was DENV-3 NS5. Surprisingly, the DENV-1 and -4 NS5 proteins were confined to the cytoplasm. Similar results were obtained at 48 h after transfection and when the DENV-1 to 4 NS5 genes were transiently expressed in Vero and BHK-21 cells (data not shown).
The same nuclear/cytoplasmic localization patterns for NS5 of the different DENV serotypes was observed when the pcGFP-DV-NS5F plasmids were transiently expressed in A549 cells (Fig. 1B) and Vero cells (data not shown) showing that fusion of GFP to the Nterminus of the different NS5 proteins did not influence their cellular localization. Compared to the analysis of NS5 localization using the FLAG epitope and IFA, weak nuclear fluorescence was observed in cells transiently expressing GFP-DV1-NS5F and GFP-DV4-NS5F. It is possible that this fluorescence was mediated by GFP itself, as it has been reported that GFP multimers with a size of >45kDa accumulate in small amounts in the nucleus (47) .
It has previously been shown that only NS5 generated by N-terminal proteolytic processing (either in the context of the viral polyprotein or when fused C-terminally to ubiquitin) could degrade STAT2, suggesting that the conformation of the N-terminal region of NS5 may affect its properties (15) . The initial amino acid of the NS5 proteins C-terminally tagged with the FLAG epitope had been changed to methionine and was not generated by proteolytic processing. The importance of the N-terminal conformation of NS5 to nuclear localization was therefore examined by constructing plasmids that encoded NS5F Cterminally fused to ubiquitin (pcUb-DV-NS5F plasmids) and using them for transient expression assays. Despite repeated attempts, a plasmid encoding a ubiquitin DENV-1 NS5 fusion protein could not be obtained. The localization of the transiently expressed NS5 proteins generated by N-terminal ubiquitin cleavage was then examined in A549 and Vero cells (Fig. 1C) . As for the NS5F proteins, the transiently expressed DENV-2 and -3 NS5F proteins that had been generated by Nterminal ubiquitin cleavage accumulated in the nucleus, whereas the DENV-4 NS5F protein was confined to the cytosol (Fig. 1C) . The cleavage of ubiquitin from the N-terminus of NS5 was verified by Western blot analysis (Fig. 1D) . Collectively the results demonstrated that there were serotype specific differences in the nuclear localization of transiently expressed NS5 in a range of cell lines.
Differential localization of DENV-1 to 4 NS5 during virus infectionTo confirm that the transient expression experiments were an accurate representation of the events that occurred during virus infection, human A549 cells and insect C6/36 cells were infected with DENV-1 to 4, and at 24 h post-infection, the localization of the respective NS5 proteins was determined by IFA using an antibody against DENV-2 NS5. As the specificity of the anti-NS5 antibody to the DENV-1 to 4 NS5 proteins varied, the antibody was preabsorbed to transfer membranes containing the respective NS5 proteins, to increase its serotype specificity. In support of the transient expression experiments, the DENV-2 and -3 NS5 proteins were localized predominantly to the nucleus whilst the DENV-1 and -4 NS5 proteins were cytoplasmically localized in both human and insect cells ( Figs. 2A and B) .
To complement the IFA analysis, the localisation of NS5 in infected cells was then examined by cell fractionation followed by Western blotting. In this experiment and subsequent studies we concentrated on the DENV-2 and -4 NS5 proteins as examples of proteins that did and did not nuclear localize, respectively. The cells were fractionated into nuclear, cytoplasmic and a cytoplasmic heavy membrane fraction previously shown to contain flavivirus RdRp activity (39, 48) . Overall, the cell fractionation experiments supported the IFA analysis as a major portion of DENV-2 NS5 was found in the nuclear fraction whereas only trace amounts of DENV-4 NS5 were detected in the nuclear fraction (Fig.  2C) . DENV replication is known to occur in intimate association with perinuclear membranes (20) (21) 40) , therefore it could not be excluded that the low amount of DENV-4 NS5 present in the nuclear fraction was due to its association with perinuclear membranes which were not removed from the nuclear membrane, as suggested by the detection of the E protein in the nuclear fraction. Compared to the IFA analysis, a greater proportion of DENV-2 NS5 was found in the cytoplasm both in the soluble and heavy membrane fractions, suggesting that the analysis of DENV-2 NS5 localization by IFA exaggerates the proportion of NS5 amount found in the nucleus.
DENV-4 NS5 does not shuttle between the nucleus and the cytoplasmIt has previously been reported that DENV-2 NS5 shuttles between the nucleus and cytoplasm using the importin-α/β import and the CRM1 mediated export pathways, respectively (31) . To exclude the possibility that DENV-4 NS5 was imported into the nucleus and rapidly exported, preventing nuclear accumulation, Vero cells transiently expressing the DENV-2 and -4 GFP-NS5F proteins were treated with LMB, a specific inhibitor of CRM1 mediated nuclear export. LMB treatment did not increase the accumulation of DENV-4 NS5 to levels detectable by IFA and CLSM providing further evidence that DENV-4 NS5 does not accumulate in the nucleus (Fig. 3A) .
Further analysis of NS5 nuclear shuttling was done by FRAP experiments. In order to conduct these experiments we made use of the weak nuclear fluorescence observed in cells expressing GFP-DV4-NS5F (see above). We first investigated the nuclear import of DENV-2 and -4 GFP-NS5F.
Vero cells transiently expressing either GFP-DV2-NS5F or GFP-DV4-NS5F were subjected to nuclear photobleaching, and the recovery of nuclear fluorescence and the corresponding change in cytoplasmic fluorescence was measured over a 6 min interval in 30 sec increments (Fig. 3B) . The relative nuclear fluorescence of cells expressing GFP-DV2-NS5F recovered in an almost linear fashion over the duration of the experiment. However, the recovery of DENV-2 NS5 nuclear fluorescence was slow and incomplete, suggesting that the major part of the cytoplasmic NS5 pool could not be rapidly transported to the nucleus to replenish the nuclear NS5 pool, supporting the earlier finding that phosphorylation differentially regulates the nuclear localization of DENV-2 NS5 (27) (28) . By contrast, cells expressing GFP-DV4-NS5F showed only a slight recovery during the first 30 seconds after photobleaching, that could be attributed to spontaneous GFP recovery after photobleaching (49) , with no further increase in nuclear fluorescence after this time.
The movement of NS5 from the nucleus to the cytoplasm was then investigated by cytoplasmic photobleaching of Vero cells expressing either GFP-DV2-NS5F or GFP-DV4-NS5F. During each bleaching cycle about 30% of the cytoplasm of a GFP expressing cell was photobleached, 29 seconds later an image was taken and the next bleaching cycle would start for a total of 11 cycles. Nuclear and cytoplasmic fluorescence values were normalized to the respective values of a transfected non-bleached neighbouring cell (Fig. 3C) . Over the course of 11 bleaching cycles the nuclear fluorescence of cells expressing GFP-DV4-NS5F was not significantly decreased (P >0.1) whereas the nuclear fluorescence in cells expressing GFP-DV2-NS5F was (P <0.005). Taken together, these experiments provide evidence that transiently expressed DENV-4 NS5 does not shuttle between the cytoplasm and the nucleus.
DENV-4 NS5 does not have a functional a/bNLSComparison of the amino acid sequence of the DENV-2 NS5 a/bNLS with the corresponding sequences of the DENV-1, -3 and -4 NS5 proteins shows that the basic clusters of amino acids essential for nuclear localization of DENV-2 NS5 (28-30) are not conserved (Fig. 4A) . We therefore examined whether the failure of DENV-4 NS5 to accumulate in the nucleus was due to the amino acid changes in the a/bNLS region or rather, inhibitory regions in the remainder of the protein. Plasmids encoding GFP N-terminally fused to the DENV-2 and -4 MTase (amino acids 1-273) and POL (amino acids 274-900) domains were transiently expressed in A549 cells and the localization of the corresponding proteins analyzed (Fig. 4B ). As observed in previous studies, the DENV-2 GFP-MTase and GFP-POL were predominantly localized throughout the cytoplasm and nucleus and the nucleus, respectively (30) (31) . By contrast, although the DENV-4 GFP-MTase protein was localized similarly to the DENV-2 GFP-MTase protein, the DENV-4 GFP-POL protein was confined to the cytoplasm, showing that the MTase domain did not inhibit DENV-4 NS5 nuclear localization. Sequences encoding the DENV-2 a/bNLS (amino acids 369-405) and the corresponding region of DENV-4 NS5, were then C-terminally fused to a tandem GFP gene construct, encoding a protein > 55 kDa in molecular mass that could only be transported to the nucleus in an active process. Transient expression of the genes encoding the 2xGFP-a/bNLS proteins in A549 cells demonstrated that the DENV-2 NS5 a/bNLS was capable of mediating the nuclear transport of a tandem GFP protein whereas the corresponding region of the DENV-4 NS5 protein did not. Taken together, the results suggested that DENV-4 NS5 amino acids 369-405 do not function as a NLS.
To further test this finding, we exchanged the DENV-2 sequences encompassing the a/bNLS or the "minimal" a/bNLS (amino acids 369-389) with the corresponding sequences of DENV-4 NS5 and vice versa in the context of plasmids encoding the GFP-NS5F proteins. Transient expression of the plasmids in A549 cells revealed that the introduction of the DENV-4 sequences into the GFP-DV2-NS5F protein abolished nuclear localization (Fig. 4C) . The introduction of the DENV-2 a/bNLS and minimal a/bNLS amino acid sequences into the GFP-DV4-NS5F protein increased the nuclear localization of DENV-4 NS5. However, compared to the nuclear localization of DENV-2 NS5, the modified DENV-4 NS5 proteins were substantially less nuclear localized (Fig. 4C) . These results suggested that the DENV-2 NS5 a/bNLS sequences were sufficient to localize the chimeric GFP-DV4-NS5 protein to the nucleus but that other regions of the DENV-4 NS5 protein also determined the efficiency of nuclear localization.
To confirm these results in the context of virus infection, sequences encoding the DENV-4 NS5 amino acids 370-401 and 370-390 were introduced into a DENV-2 infectious cDNA clone. In vitro RNA transcripts produced from the clones were used to transfect mammalian BHK-21 and insect C6/36 cells. However despite several attempts and repeated passaging of culture supernatants from the initially transfected cells to encourage reversion, it was not possible to recover DENV-2 viruses containing the DENV-4 sequences (data not shown).
Interaction of importin-α with NS5To determine if the defect in DENV-4 NS5 nuclear localization lay in the inability of the protein to interact with importin-, co-IP experiments were conducted. It is known that there are 7 isoforms of human importin- (KPNA1 -7), which are classed into 3 subfamilies (1: KPNA1, 5 and 6; 2:KPNA2 and 7 and 3:KPNA3 and 4; (50-51)). DENV-2 NS5 has previously been shown to interact with a pre-complexed murine importin- (mImp58)/importin-β heterodimer by ELISA and a pulldown assay (29) (30) . As mImp58 corresponds with the human importin- isoform KPNA2, we initially examined the interaction of DENV-2 and -4 NS5F with V5 tagged KPNA2, using proteins exogenously expressed in HEK293 cells. However, using co-IP conditions previously used to examine the interaction of KPNA2 with a FLAG tagged version of Rac1 (42) neither DENV-2 nor -4 NS5F bound KPNA2-V5, although the interaction with Rac1-F was confirmed (Fig. 5A) . The interaction of DENV-2 and -4 NS5F with KPNA2-V5 and V5 tagged versions of KPNA1, 3, 4 and 6 and KPNB1 was then examined under varying salt (75 -300 mM) and detergent (0.1 -1 % Triton X-100) conditions. No interactions were observed between DENV-2 and -4 NS5 and KPNA1, 3, 4 or KPNB1. Furthermore, it was not possible to unequivocally demonstrate an interaction between DENV-2 and -4 NS5 with KPNA2 or KPNA6 that was either specific or correlated with DENV-2 NS5 nuclear localization (data not shown). By comparison, both DENV-2 and -4 NS5 specifically bound to exogenously expressed STAT2, a known binding partner of DENV-2 NS5 (Fig. 5B) (15-16) .
Knockdown of KPNB1 but not KPNA2 affects DENV-2 NS5 nuclear localizationFollowing the results of the co-IP experiments, siRNA knockdown experiments were done to examine the requirement of KPNA2 and KPNB1 for NS5 nuclear localization. KPNA2 was knocked down in HEK293 cells before DENV-2 infection or either transient or stably induced expression of DENV-2 NS5. Only minimal amounts of KPNA2 could be detected in KPNA2 siRNA treated cells by Western blot analysis compared to non-sense siRNA treated or untreated cells (Fig. 6A) . Surprisingly, there was little or no decrease in NS5 nuclear localization between cells transfected with the KPNA2 siRNAs, non-silencing siRNAs and untransfected cells. Following the same experimental procedure, the effect of KPNB1 knock-down on DENV-2 NS5 nuclear localization was examined. In this case, although KPNB1 knock-down was not as complete as for KPNA2, there was a major decrease in the amount of nuclear localized NS5 in KPNB1 siRNA treated cells, either during DENV-2 infection or when NS5 alone was transiently or stably expressed in cells (Fig. 6B) . The knock-down of either KPNA2 or KPNB1 did not effect DENV-2 replication as determined by the amounts of NS5 protein in the cell lysates or the titer of virus in the culture supernatants ( Figs 6A, B and C) .
DENV NS5 induced IL-8 gene expression does not correlate with nuclear localizationWe previously showed that decreased NS5 nuclear localization, either during DENV-2 infection or when transiently expressed, increased IL-8 secretion (30) . It was therefore of interest to determine if the observed serotypic differences in NS5 nuclear localization correlated with differences in IL-8 gene expression. An IL-8 luciferase gene reporter assay was used to measure IL-8 gene expression in HEK293 cells transiently expressing plasmids encoding DENV-1, -2, 3 and -4 NS5F or DENV-2, -3 and -4 Ub-NS5F (Fig. 7A) . Expression of DV3-NS5F or Ub-DV3-NS5F resulted in the highest induction of luciferase expression from the IL-8 promoter, followed by DV1-NS5F and DV2-NS5F / Ub-DV2-NS5F. Luciferase gene expression driven by the IL-8 promoter was lowest in cells expressing DV4-NS5F or Ub-DV4-NS5F. This pattern was supported by qRT-PCR analysis of IL-8 mRNA amounts in HEK293 cells expressing DENV-1, -2, 3 and -4 NS5F (Fig. 7B) . The results showed that although there were serotypic differences in the ability of NS5 to induce IL-8 expression, these differences did not strictly correlate with the serotypic differences in NS5 nuclear localization.
DISCUSSION
The nuclear localization of DENV NS5 has generally been assumed to be a common feature of all DENV serotypes. However the results of this study demonstrate for the first time that there are serotypic differences in NS5 nuclear localization. Whilst the DENV-2 and -3 proteins accumulate in the nucleus, DENV-1 and -4 NS5 are predominantly if not exclusively localized to the cytoplasm. These findings were shown both by transient expression of GFP or FLAG tagged NS5 or by examination of NS5 produced during virus infection of both mammalian and insect cells. The failure of DENV-4 NS5 to accumulate in the nucleus was shown not to be due to rapid nuclear export of the protein, but rather, the failure of amino acids 369 -405 to function as a NLS.
Structural and peptide binding studies have defined 6 classes of monopartite NLS consensus sequences (52) and a consensus bipartite NLS as K/R(K/R)X 10-12 (K/R) 3/5 (where (K/R) 3/5 is defined as three of either K or R in five consecutive amino acids (26, 53) ). Comparison of the DENV-2 a/bNLS amino acid sequence with the corresponding sequences in the DENV-1, -3 and -4 NS5 proteins (Fig. 4A) shows that only the DENV-2 sequence contains the three clusters of basic amino acids originally used to identify a bipartite NLS (28) . These clusters are conserved to varying extents in the NS5 of other serotypes. Mutagenesis studies on DENV-2 NS5 have shown the importance of the first two clusters of basic amino acids (K371/K372 and K387/K388/K389, termed A1 and A2, respectively) for NS5 nuclear localization, both in vitro and during the virus lifecycle (29) (30) . In the case of DENV-4 NS5, there is only one cluster of basic amino acids (K387/K388/K389) in the region corresponding to the DENV-2 a/bNLS, which does not fit the consensus sequence for a mono or bipartite NLS, supporting the finding that DENV-4 NS5 amino acids 369-405 do not function as a NLS. For DENV-1 and -3 NS5 the situation is more complex. The dibasic K371/K372 cluster in DENV-2 is present as AQ and RK in DENV-1 and -3 respectively, whilst the A2 cluster K387/K388/K389 is substituted with the sequence RNK in DENV-1 and -3 NS5. Structural analysis of the interaction between importin- and bipartite NLS sequences has shown that a Lys is strongly preferred to Arg at the residue corresponding to DENV-2 K387 and a basic residue is preferred at following position (26, (53) (54) suggesting that DENV-1 and -3 NS5 also do not contain a bipartite NLS. However, it has previously been suggested that the sequence 363 PKAKRG in DENV-1 NS5 could function as a monopartite NLS (29) and the sequences 388 KKPR and 388 KRPR in DENV-1 and -3 NS5 could function as class II monopartite NLSs (52) . In addition to the basic clusters that mediate importin-α binding, the linker sequence in the bipartite NLS and flanking sequences can influence importin-α binding (52, (55) (56) which may contribute to the different patterns of nuclear localization observed between the DENV-1 and -3 proteins. The introduction of the DENV-2 a/bNLS into DENV-4 NS5 did not fully transfer the properties of nuclear localization to the DENV-4 protein. Previous studies have shown that both the NLS and the protein context determine the efficiency of nuclear transport (57) suggesting that other regions in DENV-4 NS5 may also contribute to its cytoplasmic localization.
Analysis of the conservation of NS5 amino acids 369-405 using the Dengue Virus Variation Database (http://www.ncbi.nlm.nih.gov/genomes/VirusVaria tion/ (58)) revealed that the sequences of the DENV serotypes used in this study represented the consensus sequence for each serotype and are highly conserved between laboratory adapted and clinical strains, but diverge amongst the different serotypes. For example, there are currently 948 DENV-2 NS5 sequences in the database, the A1 and A2 clusters are 100% and > 95% conserved, respectively. Of the currently available 101 DENV-4 sequences, none have mutations that lead to a monopartite or bipartite NLS consensus sequence (in the a/bNLS region) even though this could be achieved by a single amino acid change. This strong sequence conservation between serotypes suggests that nuclear localization may be important in a serotype specific manner.
Although there is ~80% similarity between the DENV-2 and -4 NS5 amino acid sequences 369-405, it was not possible to rescue DENV-2 viruses with the NS5 a/bNLS or minimal a/bNLS replaced by the corresponding regions of DENV-4. Analysis of the x-ray structure of the DENV-3 and WNV POL domains revealed that the a/bNLS region is comprised of two helical regions (6 and 7) linked by a loop and connects the "palm" and the "fingers" subdomains of the POL structure (45, 59) . Superimposition of structural models of the DENV-2 POL and the DENV-2 POL containing DENV-4 NS5 amino acids 370-390 or 370-401 (produced from the DENV-3 POL x-ray structure (60) revealed no overall change to the a/bNLS structure. However there were differences in the identity or orientation of specific amino acid side chains in the a/bNLS region (Fig. 4D) . The substitution of specific DENV-2 amino acids with those of DENV-4 NS5 may therefore have had an overall effect on the stability and/or enzymatic function of the POL domain in addition to their effects on NS5 localization. Previous reverse genetic analysis studies have shown that the mutation of specific amino acids in the a/bNLS region can have a major effect on virus replication. The mutation K387A/K388A, in DENV-4 (strain 814669) NS5 caused a temperature sensitive phenotype in cell culture and virus attenuation in a mouse neurovirulence model (61) . Mutation of the DENV-2 NS5 A1 and A2 clusters to Ala individually decreased virus replication whilst mutation of both clusters abolished virus replication (30) . The mutation of the A2 cluster to Ala was found to delay NS5 nuclear localization. Studies investigating the effects of mutations made to DENV-2 NS5 a/bNLS on virus replication and POL activity, using bacterially expressed NS5, have shown that only the mutation R401A/K401A (S401/K402 in DENV-4) abolished virus replication and POL activity (46, 62) whereas other mutations could reduce viral replication without effecting POL activity (46) , highlighting the pleitropic effects of mutations in the a/bNLS region.
Previous studies using an ELISA based and column pull down assays showed that DENV-2 NS5 and/or the NS5 a/bNLS interacted with the murine equivalent of human KPNA2 complexed to importin-β (28-30). However, it was not determined whether DENV-2 NS5 could bind to other importin- isoforms. In addition, by analogy to the species specific difference in the binding of NS5 to murine and human STAT2 (17) there may have been differences in the binding of NS5 to murine and human importin-. Therefore we analyzed the interaction of DENV-2 and -4 NS5 with 5 human importin- isoforms, representative of the three importin- subfamilies (51) after exogenous expression in mammalian cells. However, using a range of binding conditions, we could neither detect binding of DENV-2 or -4 NS5 to importin- isoforms 1, 3 and 4 nor unequivocally detect an interaction with KPNA2 or 6 that was specific or correlated with DENV-2 NS5 nuclear localization. Previous studies using yeast two hybrid analysis have not detected a direct interaction between any of the importin- isoforms and NS5 of DENV-2 (32,63), DENV-1 or other flaviviruses (64) suggesting that interaction studies require specific conditions that allow the formation of a stable complex between NS5 and the importin-/importin-β heterodimer perhaps reflecting the transient nature of the interaction.
As an alternative to interaction studies, we examined the localization of DENV-2 NS5 in cells in which KPNA2 and KPNB1 had been knocked down. Although we observed strong knockdown of KPNA2, there was little to no effect on DENV-2 NS5 nuclear localization in infected cells or cells either transiently or stably expressing DENV-2 NS5. By contrast, the knockdown of KPNB1 severely reduced or abolished the nuclear localization of NS5. There are a number of possible explanations for these results. First, KPNA2 is reported to be the most abundant importin isoform in many eukaryotic cells (65) (66) and there may have still been sufficient KPNA2 after knockdown to mediate DENV-2 NS5 nuclear transport. Second, there may be redundancy in the binding of DENV-2 NS5 to importin- isoforms and we did not test binding to KPNA5 and 7 although other members of these subfamilies were tested. Finally, previous studies have shown that KPNB1 can bind to a region of DENV-2 NS5 known as the bNLS (amino acids 320-368) (29, 32) . However, binding only occurred when the a/bNLS was absent. In the absence of KPNA2, KPNB1 may be able to function directly to transport NS5 to the nucleus, which could not occur when KPNB1 was knocked down.
In many cases the nuclear import of viral proteins is required for virus replication, however viruses also actively target specific karyopherins to inhibit the import of transcription factors that activate antiviral responses (67) . For example, the Ebola virus VP24 protein binds to human KPNA1, 5 and 6, preventing the binding and subsequent nuclear translocation of phosphorylated STAT1, inhibiting IFN signalling (68-69) whilst the Hantaan virus N protein binds to KPNA1, 2 and 4, inhibiting the nuclear translocation and activity of NF-κB (70). The results of our and a recent study (46) suggest that nuclear localization of DENV NS5 is not strictly essential for DENV replication. However, previously we found that mutations in DENV-2 NS5 that delay nuclear localization lead to decreased virus replication (30) . The nuclear localization of NS5 or its interaction with the nuclear import/export machinery may therefore play an auxiliary role in enhancing virus production, for at least the DENV-2 serotype. It has previously been shown that the cellular localization of DENV-2 NS5 affects IL-8 production (30) (31) 43) . In this study we found that serotypic differences in NS5 nuclear localization did not correlate with IL-8 expression. By contrast, we found that both DENV-2 and -4 NS5 bound to STAT2, extending the previous finding that DENV-2 and -1 bind STAT2 (15) (16) (17) which is likely to be a common feature of DENV NS5. Therefore there appear to be commonalities and differences in the way that NS5 of different DENV serotypes interacts with the host cell. It is known that different flavivirus NS5 proteins use distinct mechanisms to perturb type I IFN signalling (11) (12) (13) (14) (15) (16) . It remains to be investigated whether the effects of the serotypic differences in DENV-2 NS5 nuclear localization reported in this study, are compensated by other mechanisms or play a specific role in pathogenesis. It has recently been shown that inhibition of nuclear import pathways has potential as an antiviral strategy against DENV-2 (71). However this study demonstrates that when investigating antiviral strategies against DENV, that serotypic differences need to be taken into account. , with all pre-bleached RFU values set to 1. The significance of the variation between the nuclear fluorescence before bleaching and after 11 bleaching cycles was determined using a two tailed Student's t-test and is shown for cells expressing GFP-DV2-NS5F and GFP-DV4-NS5F. A. HEK293 cells were co-transfected with either a plasmid coding for KPNA2-V5 or no plasmid (con) together with pcDV2-NS5F (DV2-NS5F), pcDV4-NS5F (DV4-NS5F) or pc3xFLAG-Rac1 (Rac1-F). Co-IP analysis was done using anti-V5 beads. The immunoprecipitates (IP) and total cell lysates (Input) were analyzed by SDS-PAGE and Western blotting using an anti-FLAG antibody to detect NS5F and Rac1-F and an anti-V5 antibody to detect KPNA2-V5. (*) represents a non-specific band recognized by the anti-V5 antibody. B. HEK293 cells were co-transfected with either pGFP-DV2-NS5F (GFP-DV2-NS5F), pGFP-DV4-NS5F (GFP-DV4-NS5F) or pEGFP (GFP) together with a plasmid coding for human STAT2. Co-IP analysis was conducted using GFP-Trap beads and TBS containing 150 mM NaCl and 1% Triton X-100 for cell lysis and washing. The immunoprecipitates (IP) and total cell lysates (Input) were analyzed by SDS-PAGE and Western blotting using anti-STAT2 and anti-GFP antibodies to detect STAT2 and GFP-NS5 / GFP respectively. All co-IP assays were done 24 h post-transfection. knockdown efficiency by SDS-PAGE and Western blot analysis of extracts from the cells using the same antibodies and an antibody against GAPDH as a loading control. B. The experiment described in (A) was repeated except that the siRNA pool against KPNA2 was replaced with a siRNA pool against KPNB1. The efficiency of KPNB1 knockdown was assessed by IFA and Western blot analysis using antibodies against KPNB1. The immunostaining of DENV infected cells using anti-NS5 and anti-KPB1 antibodies were done on duplicate samples as both antibodies were raised in rabbits. In this case only the CLSM images of the anti-NS5 and DAPI stained cells were overlayed. C. The titers of virus in the culture supernatants of DENV-2 infected HEK293 cells transfected with either a non-sense (nons), a KPNA2, a KPNB1 siRNA pool or left untreated (untr) 48 h prior to infection were determined by plaque assay. The titers were determined using two independent DENV-2 infected cell samples at 24 and 48 h post infection. A. HEK293 cells were transfected with either pcDV1-NS5F (DV1-NS5F), pcDV2-NS5F (DV2-NS5F), pcUb-DV2-NS5F (Ub-DV2-NS5F), pcDV3-NS5F (DV3-NS5F), pcUb-DV3-NS5F (Ub-DV3-NS5F), pcDV4-NS5F (DV4-NS5F) and pcUb-DV4-NS5F (Ub-DV4-NS5F), pMal as a positive control, or pcDNA3.1 as a negative control together with pRL-TK, expressing Renilla luciferase and an IL-8 promoter driven firefly luciferase reporter plasmid (43) . At 24 h post-transfection the cells were harvested and luciferase activities measured. Each value represents the average of 3 independent experiments and is shown in relative light units (RLU). B.
qRT-PCR was done using RNA extracted from duplicate samples described in (A). IL-8 and neomycin resistance (NeoR) gene transcripts were quantified. The NeoR gene transcripts were quantified to control for differences in the levels of transfection efficiency, and IL-8 mRNA levels were normalized against NeoR expression. Each bar represents the average of 3 independent experiments. The values are expressed as the fold change in IL8 transcript amount compared to that induced in cells transfected with pcDNA3.1 and are depicted using a logarithmic scale. Figure 1 by guest on August 17, 2017 
